BETA

3 Amendments of Dan JØRGENSEN related to 2010/0208(COD)

Amendment 20 #
Proposal for a regulation - amending act
Recital 2 a (new)
(2a) The Commission should ensure, as a priority, the implementation of the Environment Council Conclusions adopted on 4 December 2008, namely a proper implementation of the legal requirements laid down in Annex II of Directive 2001/18/EC for the risk assessment of GMOs. In particular, the Commission should ensure that the long- term environmental effects of GM crops as well as their potential effects on non- target organisms are rigorously assessed; that the characteristics of the receiving environments and the geographical areas in which GM plants may be cultivated are duly taken into account; that the potential environmental consequences brought by changes in the use of herbicides linked to herbicide-tolerant GM crops are assessed; that Member States’ scientific concerns are duly taken into account; that independent research on the potential risks of GMOs is conducted; that the necessary resources are secured for such research; and that independent researchers are given access to all relevant material, while respecting intellectual property rights.
2011/03/17
Committee: ENVI
Amendment 39 #
Proposal for a regulation - amending act
Recital 8
(8) According to the legal framework for the authorisation of GMOs, the level of protection of human/animal health and of the environment chosen in the EU cannot be revised by a Member State and this situation must not be altered. However Member States may adopt measures restricting or prohibiting the cultivation of all or particular GMOs in all or part of their territory on the basis of grounds relating to the public interest other than those already addressed by the harmonised set of EU rules which already provide for procedures to take into account the risks that a GMO for cultivation may po. Those measures may be based on grounds relating to environmental or health impacts which might arise from the deliberate release or the placing on the market of GMOs, and which are complementary to those examined during the risk assessment process conducted under Part C of Directive 2001/18/EC or which have not been addressed or have not been adequately dealt with as part of that assessment. National measures could be based inter alia on the following grounds: the absence or lack of sufficient data on the potential negative impacts of GMOs on the environment or public health in a Member State, or persisting scientific uncertainty on possible environmental or health impacts examined during the risk assessment under Part C of Directive 2011/18/EC; the prevention of negative impacts on the environment or health caused by farming practices linked to the cultivation of GMOs; the protection of ecologically sustainable farming practices enhancing the fertility of soils and biodiversity. The national measures may also be based on health and the environmentother legitimate factors which might arise from the deliberate release or the placing on the market of GMOs. Those measures should furthermore be in conformity with the Treaties, in particular as regards the principle of non discrimination between national and non national products and Articles 34 and 36 of the Treaty on the Functioning of the European Union, as well as with the relevant international obligations of the Union, notably in the context of the World Trade Organisation.
2011/03/17
Committee: ENVI
Amendment 79 #
Proposal for a regulation - amending act
Article 1 – point 1
Directive 2001/18/EC
Article 26 b – paragraph 1– point a
(a) those measures are based on grounds other than those related to the assessment of the adverse efferelated to environmental or health impacts which might arise from the deliberate release or the placing on the market of GMOs, and which are complementary to those examined during the risk assessment process conducted under Part C of this Directive or which have not been addressed or have not been sufficiently dealt with as part of this assessment. National measures could be based inter alia on the following grounds: (i) the absence or lack of sufficient data on the potential negative impacts of GMOs on the environment or public health in a Member State, or persisting scientific uncertainty on possible environmental or health impacts examined during the risk assessment under Part C of this Directive; (ii) the prevention of negative impacts on health and environmentthe environment or health caused by farming practices linked to the cultivation of GMOs; (iii) the protection of ecologically sustainable farming practices enhancing the fertility of soils and biodiversity. The national measures may also be based on other legitimate factors which might arise from the deliberate release or the placing on the market of GMOs;
2011/03/17
Committee: ENVI